3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Ovarian Neoplasms
3
Fallopian Tube Neoplasms
3
Uterine Neoplasms
2
Prostatic Neoplasms
2
Neoplasms
2
Neoplasm Metastasis
2
Multiple Myeloma
2
Lymphoma
2
Lung Neoplasms
2
Hematologic Neoplasms
2
Carcinoma, Renal Cell
2
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Triple Negative Breast Neoplasms
1
Thyroid Neoplasms
1
Stomach Neoplasms
1
Rectal Neoplasms
1
Pancreatic Neoplasms
1
Myelodysplastic Syndromes
1
Muscle Invasive Bladder Cancer
1
Meningeal Carcinomatosis
1
Melanoma
1
Leukemia, Myeloid, Acute
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Glioma
1
Esophageal Squamous Cell Carcinoma
1
Esophageal Neoplasms
1
Endometrial Neoplasms
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Interventions
Interviews as Topic
3
Educational Status
3
Specimen Handling
2
Palliative Care
2
Methods
2
Early Intervention, Educational
2
veliparib
1
spartalizumab
1
siltuximab
1
pamiparib
1
dinaciclib
1
cabozantinib
1
Pharmacogenomic Variants
1
Patient Comfort
1
Paclitaxel
1
Nutrition Assessment
1
Mindfulness-Based Stress Reduction
1
Mindfulness
1
Magnetic Resonance Spectroscopy
1
Health Promotion
1
Diet Therapy
1
Biopsy
1
Behavior Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Advanced Malignant Solid Neoplasm
×
adavosertib
×
1 year
×
Clear all
No trials found.